Newborn affected by maternal noxious substance, unspecified
ICD-10 P04.9 is a billable code used to indicate a diagnosis of newborn affected by maternal noxious substance, unspecified.
The code P04.9 is used to classify newborns who are affected by maternal noxious substances, which may include drugs, alcohol, or tobacco that are transmitted through the placenta or breast milk. This condition can lead to a variety of complications in the newborn, including withdrawal symptoms, growth restrictions, and developmental delays. Maternal substance use during pregnancy can have profound effects on the fetus, leading to conditions such as Neonatal Abstinence Syndrome (NAS) or Fetal Alcohol Spectrum Disorders (FASD). The clinical presentation may vary widely, and the severity of symptoms can depend on the type and amount of substance used, as well as the timing of exposure during gestation. Accurate coding requires a thorough understanding of the maternal history and the clinical manifestations observed in the newborn. Documentation should include details about the maternal substance use, any observed symptoms in the newborn, and the management provided in the neonatal period.
Detailed maternal history, including substance use patterns, and clinical observations of the newborn.
Newborns presenting with withdrawal symptoms, low birth weight, or developmental delays in the NICU.
Consideration of the timing of maternal substance use and its correlation with neonatal outcomes.
Comprehensive assessment of the newborn's growth and development, including any long-term follow-up needs.
Pediatric evaluations of children with developmental delays or behavioral issues stemming from prenatal exposure.
Awareness of the long-term implications of prenatal substance exposure on pediatric health.
Used in conjunction with P04.9 when assessing a newborn with maternal substance exposure.
Document the newborn's clinical status and any interventions required.
Neonatologists should ensure thorough documentation of maternal history and newborn assessment.
Documentation should include a detailed maternal history of substance use, specific symptoms observed in the newborn, and any interventions provided. This information is crucial for accurate coding and billing.
